Vote in the European Parliament

Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

Pernille Weiss – Recital 11 – Am 339
Date: 10.04.2024·Reference: A9-0140/2024
Rapporteur: Pernille Weiss-Ehler

Overall Result

Rejected
  • 112 For
  • 464 Against
  • 6 Abstention
  • 123 Did not vote
Amendment— You are viewing a sub-vote (amendment) of the main vote.Amendment 339 · Tabled by IDView amendment at the EP ↗
Amendment wording

Tabled by Aurélia Beigneux, Anders Vistisen

… enable innovation and promote competitiveness of the Union pharmaceutical industry, in particular Removed: SMEs. Added: SMEs or other marketing authorisation holders producing on the EU territory regardless of their size. In this respect a balanced system of incentives is proposed that rewards … medical need and innovation that reaches patients and improves access across the Removed: Union. Added: Union and its Outermost regions. To make the regulatory system more efficient and innovation-friendly the Directive also …

Wording as published by the EP, in English. PE760.538

← Back to Main Vote
Status and procedure

Outcome as recorded by the European Parliament.

Vote held on
Latest recorded step
Committee stage · (32 days ago)
Next scheduled step
Plenary · (in 12 days)

Procedure timeline

2023/0132(COD) · COD

Recorded procedure activities. These do not establish whether a law has entered into force.

  1. Recorded: Referral19 days until the next step
  2. Recorded: Committee stage170 days until the next step
  3. Recorded: Plenary453 days until the next step
  4. Recorded: Negotiations274 days until the next step
  5. Recorded: Committee stage204 days until the next step
  6. Recorded: Referral4 days until the next step
  7. Latest recorded: Committee stage32 days since this step began
  8. Planned: Plenary
Recorded activities (21)
  1. Referral to committee
  2. Committee report tabled
  3. Committee amendments tabled
  4. Committee amendments tabled
  5. Committee amendments tabled
  6. Committee amendments tabled
  7. Committee opinion adopted
  8. Committee opinion adopted
  9. Committee report adopted
  10. Tabling for plenary
  11. Parliament’s first-reading position with amendments
  12. Plenary debate
  13. Plenary vote
  14. Plenary vote results
  15. Interinstitutional negotiations
  16. Interinstitutional negotiations
  17. Interinstitutional negotiations
  18. Interinstitutional negotiations
  19. Provisional agreement approved in committee
  20. Referral to committee
  21. Committee report tabled
Scheduled activities (not confirmation of completion)
  1. Plenary debate
  2. Plenary vote
  3. Plenary vote

Procedure file (OEIL) · European Parliament data
Retrieved:

Sources

Data: EP Open Data API

What is this about?

  • Revision of the EU pharmaceutical codex after 20 years.
  • Focus on innovation , access and environmental sustainability .
  • Strengthening strategic autonomy in the health sector.
Source: AI Summary with Mistral

Vote by political group

How the political groups voted

Members

Showing 10 of 705

Vote Position
NameCountryGroupVote Position
ItalyNI
For
ItalyNI
For
FinlandNI
For
GermanyPfE
For
ItalyNI
For
ItalyNI
For
SpainNI
For
PolandECR
For
BelgiumPfE
For
ItalyNI
For
Show more
Follow us on Instagram@checksomevotes@checksomevotes_en